Iron supplementation decreases plasma zinc but has no effect on plasma fatty acids in non-anemic women.
Study Goal
The researchers aimed to determine the effect of iron supplementation on fatty acid desaturase activity in young women.
Results Summary
Iron supplementation improved iron status but had no significant effect on desaturase activity. A decrease in plasma zinc concentrations was observed in the supplemented group, suggesting an antagonistic interaction between iron and zinc.
Population
Young women (mean age ~25 years, BMI ~21.5 kg/m²)
Effective Dosage
37.4 mg of elemental iron daily
Duration
12 weeks
Interactions
Antagonism between iron and zinc noted (decreased plasma zinc concentrations in supplemented group)
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
iron supplementation | increase | serum ferritin concentrations | subjects assigned to SG | - | increased significantly | #1 |
iron supplementation | no change | serum ferritin concentrations | CG | - | were unchanged | #2 |
iron supplementation | no change | serum iron concentrations | - | - | were not significantly changed | #3 |
iron supplementation | decrease | plasma zinc concentrations | SG | - | were decreased significantly | #4 |
iron supplementation | no change | plasma zinc concentrations | CG | - | were similar to baseline values | #5 |
iron supplementation | no change | plasma fatty acids, phospholipid fatty acids, and desaturase activities | - | - | were not significantly affected | #6 |
iron supplementation | increase | Δ6-desaturase activity | SG | - | was correlated positively | #7 |
low dose iron | increase | iron status | non-anemic women | - | improves | #8 |
low dose iron | no change | desaturase activity | non-anemic women | - | has no significant effect | #9 |
Limited information is available on the role of iron in fatty acid metabolism in humans. We hypothesized that iron supplementation will increase desaturase activity, and so, the aim of this study was to determine the effect of iron supplementation on fatty acid desaturase activity in young women. Participants were randomly assigned to a control group (CG) or supplementation group (SG) who were provided with 37.4 mg of elemental iron daily for 12 weeks. Forty women completed the trial, n = 19 in CG and n = 21 in SG. The mean ages were 25.2 and 24.6 years, and body mass indices were 21.8 and 21.2 (kg/m(2)) in CG and SG, respectively. Serum ferritin concentrations increased significantly (P < .01) in subjects assigned to SG but were unchanged in CG. Serum iron concentrations were not significantly changed. Plasma zinc concentrations at the end of the intervention were similar to baseline values for individuals in CG but were decreased significantly (P = .004) in SG. Plasma fatty acids, phospholipid fatty acids, and desaturase activities, expressed as precursor-to-product ratios, were not significantly affected by the intervention, although in SG the concentration of serum ferritin was correlated positively (P < .05) with Δ6-desaturase activity. Supplementing non-anemic women with low dose iron improves iron status but has no significant effect on desaturase activity. The lack of a clear effect on an indirect indicator of desaturase activity may be related to the antagonism between iron and zinc, as illustrated by the decrease in plasma zinc concentrations in women who were supplemented with iron.